Retatrutide

Retatrutide is a multi-agonist research peptide studied for activity at GLP-1, GIP, and glucagon receptors in metabolic research models.

Investigated in controlled settings for receptor signaling, appetite/energy-balance pathways, and metabolic biomarker endpoints relevant to weight-management research.

For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.

What's Included:

• 15mg or 30mg lyophilized peptide (select size)

• Single-use research vial

• Lab-tested for purity and identity

• Certificate of Analysis included

Research Applications:

• GLP-1 receptor signaling research

• GIP receptor pathway studies

• Glucagon receptor investigations

• Metabolic-regulation models

• Appetite and energy-balance research

• Weight-management endpoint studies

FAQ:

• Q: What makes it a "triple agonist"? A: Activates three receptors—GLP-1, GIP, and glucagon—for multi-pathway metabolic research.

• Q: How does it differ from GLP-1-only agonists? A: Retatrutide's triple activity provides broader metabolic research models.